Literature DB >> 18210111

[Pathogenesis and morphology of hemophagocytic syndrome in the spleen].

S Gattenlöhner1, H K Müller-Hermelink.   

Abstract

Hemophagocytic syndrome (macrophage activation syndrome) is a group of disorders characterized by clinical, histological and biological symptoms of T-lymphocytes/NK cell-driven macrophage stimulation with subsequent hemophagocytosis which can be observed in various organs, particularly in the bone marrow and spleen. The main clinical symptoms include cytopenia, multiple organ dysfunction, fever unresponsive to antibiotics, hepatosplenomegaly and rash. Besides rare inherited immune system anomalies (primary hemophagocytic syndrome), the most prevalent etiologies of hemophagocytic syndrome are infections (viral, bacterial and parasitic), cancers, lymphoproliferative disorders and systemic diseases. Hemophagocytic syndrome is treated with immunosuppressives, cytostatic drugs, plasmapheresis and intravenous immunoglobulins/anti-TNF antibodies and due to the multiorgan involvement and the associated high mortality, recognition of early serum changes, such as very high levels of ferritin is mandatory. The most relevant histological changes are the increase of histiocytes showing evidence of phagocytosis of erythroid cells, platelets and granulocytes as well as in the spleen a rarefaction of the white pulpa with lack of lymph follicles and abundant lymphocytes, plasma cells and plasma cell precursors in the pulpa cords.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18210111     DOI: 10.1007/s00292-008-0970-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   0.973


  26 in total

Review 1.  [Macrophage activation syndrome, hemophagocytic syndrome].

Authors:  A Pradalier; F Teillet; J-L Molitor; J-C Drappier
Journal:  Pathol Biol (Paris)       Date:  2004-09

2.  [A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis].

Authors:  T Imagawa; S Katakura; M Mori; Y Aihara; T Mitsuda; S Yokota
Journal:  Ryumachi       Date:  1997-06

3.  Hemophagocytic syndrome. Differential diagnostic aspects in a case of well-differentiated malignant histiocytosis.

Authors:  H P Horny; R Inniger; E Kaiserling; F W Busch
Journal:  Pathol Res Pract       Date:  1988-02       Impact factor: 3.250

4.  Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome.

Authors:  Gavivann Veerakul; Kleebsabai Sanpakit; Voravarn S Tanphaichitr; Chularatana Mahasandana; Nongnapa Jirarattanasopa
Journal:  J Med Assoc Thai       Date:  2002-08

5.  An elderly patient with hemophagocytic syndrome due to severe mycoplasma pneumonia with marked hypercytokinemia.

Authors:  Ryusuke Mizukane; Jun-ichi Kadota Ji; Toshiyuki Yamaguchi; Takakazu Kiya; Hiromichi Fukushima; Masao Nakatomi; Shigeru Kohno
Journal:  Respiration       Date:  2002       Impact factor: 3.580

6.  Histiocytosis syndromes in children. Writing Group of the Histiocyte Society.

Authors: 
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

7.  Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.

Authors:  L Oehler; M Foedinger; M Koeller; M Kollars; E Reiter; B Bohle; S Skoupy; G Fritsch; K Lechner; K Geissler
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

8.  Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia.

Authors:  D Hasegawa; S Kojima; E Tatsumi; A Hayakawa; Y Kosaka; H Nakamura; M Sako; Y Osugi; S Nagata; K Sano
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

9.  Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation.

Authors:  H J Moshage; J A Janssen; J H Franssen; J C Hafkenscheid; S H Yap
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

10.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

Authors:  J Maciejewski; C Selleri; S Anderson; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

View more
  1 in total

1.  [Multifocal manifestation of Rosai-Dorfman disease. A rare case of purely extranodal sinus histiocytosis in the elderly].

Authors:  I Ott; M Weber; S Gattenlöhner; K Schwager; R Hagen; G Baier
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.